Welcome back to Healthy Innovations! 👋
After the wild updates out of the 2026 Beijing World Humanoid Robot Games – including a humanoid smashing Usain Bolt’s 100m record – it felt like the perfect week to share a robot-focused newsletter.
Robots in healthcare are not new – surgical systems like the da Vinci have been assisting clinicians for decades. But this week’s story is about a different kind of machine: robots that handle the front end of care. They don’t make medical decisions. They do the repeatable setup work (vitals, intake questions, forms), and then hand everything to a clinician.
In other words: the robot collects the data. Your doctor still decides what it means.
Let’s dive in!
When your checkup starts with a robot
Ged Cashley had a cardiac arrest in 2018. Since then, the 72-year-old has had annual heart checks at Erskine Medical Practice in Dundee, Scotland. His most recent one started differently: a three-foot-tall robot called Teme met him in the waiting room and walked him through unwrapping a blood pressure cuff and positioning his arm, then shared his results with him before he ever sat down with a clinician.
"It's a bit odd at first, but you soon get used to it," Ged says.
Teme isn't a one-off experiment. It's Scotland's entry into a wave of similar machines now running in hospitals and clinics across Europe and Asia, all built around the same idea: let a robot handle the repeatable, low-judgment first minutes of a health visit, so the human on duty spends their time on the parts that actually need a human.
The robot collects your vitals. It doesn't make the diagnosis.
Teme and its counterparts elsewhere belong to a category researchers call socially assistive robots: machines built not to diagnose or treat, but to guide a person through a task using speech and simple prompts, the way a well-trained intake assistant would. Teme talks a patient through the blood pressure cuff and reads the result back to them. It doesn't interpret what the number means.
In Scarborough, UK, a similar robot named DAISY, short for Diagnostic Artificial Intelligence System, does the equivalent job in an emergency department. It asks a patient about their symptoms and guides them through vital sign checks, then hands a compiled report to the clinician who makes every actual diagnostic decision. The robot is collecting; the human is still deciding.

Image source: DAISY, York and Scarborough Teaching Hospitals NHS Foundation Trust
Why the first ten minutes of your GP appointment are spent on paperwork, not on you
Dr. Gillian Chin, Ged's GP, described the problem the robot is aimed at: "The first part of almost every patient consultation is spent collecting basic information." That collection step doesn't require medical training, but it does require a trained person's time, and in general practice, time is the scarce resource. Chin says demand on the system "is increasing at a higher rate than the number of appointments and capacity we're able to offer."
It's the same bottleneck an airport used to have at check-in.
Printing a boarding pass and tagging a bag never required an airline employee with years of training, but for decades every passenger needed one anyway, because nobody had built a machine reliable enough to do it instead. Self-service kiosks didn't replace check-in staff so much as free them for the passengers who actually needed a person: a missed connection or a wheelchair transfer.
Healthcare robots are making the same trade with the same logic, just a decade or two behind aviation.
Where else this is already running, and what happened
Dundee's HEART-POD trial, a two-day pilot with 12 patients run with the National Robotarium at Heriot-Watt University, found the robot cut consultation time in half. That's a promising early signal from a small sample.
Elsewhere, the pattern is showing up at real scale.
Bangkok, Thailand: At a large public hospital handling hundreds of thousands of outpatient visits a year, three robots called Dinsaw Intelligent OPDs check patients in, verify ID, and record blood pressure, height, and weight. Patients were hesitant at first. Usage grew substantially over the following year as trust built, and the share of visits needing staffed, manual registration fell.
Scarborough, UK: DAISY has been running a six-month emergency department pilot launched in early 2025, funded through a hospital charity legacy and led by consultant Dr. Ol'Tunde Ashaolu with the University of York. The aim, Ashaolu says, is straightforward: "Patients survive more and live better lives when their ailments are identified and treated at the earliest stage."
Singapore: Where one in four residents will be over 65 by 2030, the technology has branched beyond vital signs entirely. A robot called Dexie leads exercise and cognitive games for dementia inpatients at SingHealth Community Hospitals, with early reporting showing gains in engagement.

Image source: Dexie from Dex-Lab
Paris, France: The National Robotarium, Teme's developer, has also trialled a conversational robot called ARI in the memory clinic waiting area at Assistance Publique Hôpitaux de Paris, to greet patients and answer questions
Helsinki, Finland: A robot called Välkky, with sensor-covered "electronic skin," was piloted at Laakso Hospital in Finland to take vital signs and help move equipment, concluding with what the hospital called encouraging results.
The real barrier isn't the technology, it's whether patients trust it
One major caveat, is trust rather than capability. In the Dundee trial, some patients didn't want to discuss their health with a robot in an open waiting room, and Bangkok's adoption only climbed after a full year of patients getting used to the idea.
The Royal College of GPs Scotland frames the ceiling clearly. Its vice chair, Dr. Chris Williams, told the BBC: "Technology should be seen as a tool to support healthcare professionals, not replace them. The human relationship between patients and clinicians cannot be replicated by technology alone." Take the form-filling off the appointment, and the appointment gets to be about the patient again.
Back to Ged
Ged Cashley will keep having his annual heart checks, robot or not. What changed in that Dundee waiting room was small on his end, a machine wrapped the cuff around his arm instead of a nurse, and considerable on his GP's end: half her consultation time back, to actually talk to him. Bangkok's experience suggests that unease fades faster than expected once people get a few visits in.
What matters beyond this one waiting room is simple: the most valuable part of a clinical visit often isn’t the “medical-looking” routine – it’s the human attention that remains once the repeatable steps are handled.
Innovation highlights
🧬 AI finds blood's aging switch. Aging blood stem cells aren't broken, they've just switched teams. Tohoku University researchers trained an AI model on 30 million cells' worth of data, then scanned 160,000 young and aged blood stem cells, narrowing 143 candidate genes down to one: Pbx1. Switching it on in young cells reproduced most features of aging, including a shift toward more platelets and fewer red blood cells. A single control point like this could eventually let researchers dial blood aging up or down, not just describe it.
🚁 The ambulance that flies solo. A rural North Carolina county just became the first place in the US to send a paramedic to a 911 call by air taxi. Flight paramedic Quinn Reece flew a single-seat Pivotal BlackFly eVTOL to two emergency scenes, beating the ground ambulance by roughly 20 minutes on one. The aircraft can't carry a patient back, so it's a faster first responder, not a replacement for transport. In sparse, wooded counties where minutes decide outcomes, that head start alone could matter.
🧠 A gentler jolt restores speech. Deep brain stimulation is usually tuned to one high frequency. Pittsburgh researchers found that dialing it down, to 50-80 Hz instead of the usual 130, improved speech and swallowing in a patient with severe traumatic brain injury, with word intelligibility gains of up to 20%, well past the 7% threshold considered clinically meaningful. More than 5 million Americans live with these deficits, and a larger trial is now recruiting to see whether the effect holds.
🦠 A probiotic that skips the jab. Shanghai researchers have engineered a probiotic, nicknamed Gift, that stays dormant at normal blood sugar and switches on to release GLP-1, the same hormone class as Ozempic, only when glucose rises. In animal testing it matched Ozempic's effect without an injection. The team has filed patents and says a version could reach US shelves as a health supplement within two years. If it holds up in humans, glucose control could become something you eat rather than inject.
Company to watch
🤖 Endorobotics has taken a refreshingly practical route into surgical robotics: instead of asking hospitals to buy an entirely new operating system, its robotic arm simply clips onto the endoscopes they already have. Guided in through the mouth or anus, it lets surgeons remove early-stage stomach and colorectal cancers without a single incision, which quietly solves one of the field's biggest headaches, most robotic platforms demand hospitals learn and budget for a whole new setup.
The South Korean company recently became the first from its country to win the same FDA product classification as Intuitive's da Vinci, and just signed a global exclusive distribution deal with Olympus, the world's largest endoscopy company. Small, clever, and now backed by serious reach.

Image source: EndoRobotics
Weird and wonderful
Children already do this, quietly, and most of us never notice: lose part of a fingertip early enough, and it can regrow – nail, bone, nerve, and all. Adults lose that ability almost entirely. “Why some animals can regenerate and others, particularly humans, can’t is a big question that has been asked since Aristotle,” says Texas A&M’s Dr. Ken Muneoka, who has spent a career chasing the answer. His team may have found a switch: apply one growth factor (FGF2) after a wound has closed, then a second (BMP2) a few days later, and mouse fingertips rebuilt themselves from scratch – nail, bone, and nerve – without added stem cells, regardless of which cells they started from.
Stanford scientists digging into the same mystery found the real gatekeeper isn’t genetics – it’s texture. Stiff, densely packed collagen shuts regeneration down; soft tissue rich in hyaluronic acid lets it through, and a protein called HAPLN1 seems to do double duty, reducing scarring while nudging bone to regrow. Break down that hyaluronic acid experimentally and the whole process stalls – proof the softness itself is doing the work, not just along for the ride.
As one Texas A&M researcher put it, “once you show that regeneration can be activated, it opens the door to asking entirely new questions.”

Image created using Canva AI
Thank you for reading the Healthy Innovations newsletter!
Keep an eye out for next week’s issue, where I will highlight the healthcare innovations you need to know about.
Have a great week!
Alison ✨
P.S. If you enjoyed reading the Healthy Innovations newsletter, please subscribe so I know the content is valuable to you!


